CS logo
small CS logo
Dermatologische Gemeinschaftspraxis Dres. Quist

Mainz, Germany
Dermatologist in Mainz, Rhineland-Palatinate
Haifa-Allee 20, 55128 Mainz

About Dermatologische Gemeinschaftspraxis Dres. Quist


"Dermatologische Gemeinschaftspraxis Dres. Quist - Ihre Hautärzte in Rhein-Main. Wir sind Spezialisten für Hautmedizin, Ästhetik und Forschung in Mainz und dem Rhein-Main-Gebiet."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Dermatologische Gemeinschaftspraxis Dres. Quist


During the past decade, Dermatologische Gemeinschaftspraxis Dres. Quist conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Dermatologische Gemeinschaftspraxis Dres. Quist


According to Clinical.Site data, the most researched conditions in "Dermatologische Gemeinschaftspraxis Dres. Quist" are "Atopic Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Psoriasis" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Dermatologische Gemeinschaftspraxis Dres. Quist" in a lesser frequency.

Clinical Trials Intervention Types at Dermatologische Gemeinschaftspraxis Dres. Quist


Most popular intervention types in "Dermatologische Gemeinschaftspraxis Dres. Quist" are "Drug" (3 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Dupilumab 300 mg" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dermatologische Gemeinschaftspraxis Dres. Quist


The vast majority of trials in "Dermatologische Gemeinschaftspraxis Dres. Quist" are 5 trials for "All" genders.

Clinical Trials Status at Dermatologische Gemeinschaftspraxis Dres. Quist


Currently, there are NaN active trials in "Dermatologische Gemeinschaftspraxis Dres. Quist". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dermatologische Gemeinschaftspraxis Dres. Quist, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dermatologische Gemeinschaftspraxis Dres. Quist, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".